SlideShare ist ein Scribd-Unternehmen logo
1 von 2
Downloaden Sie, um offline zu lesen
XCELLERATE®
MONITORING
Xcellerate Monitoring is an award-winning unique solution that
mitigates clinical trial risk by integrating and managing operational,
clinical and master data.
Leverage near real-time data with risk-based, adaptive site monitoring
to identify issues and trigger targeted actions that proactively mitigate
threats to a clinical trial’s success.
Overview
In today’s competitive landscape, reducing risk
is critical to prevent costly trial delays, which
can result in sales losses of up to $8 million per
day*. With traditional monitoring accounting
for 20 to 30% of clinical trial costs, sponsors are
revisiting their monitoring strategies to increase
efficiencies, reduce risks and optimize results.
Xcellerate Monitoring provides an innovative
solution for the entire study team to integrate,
centralize and visualize operational and clinical
risk data with a tiered approach to risk assessment.
With enhanced visibility into trial performance and risk-based monitoring (RBM) practices, the study
team can determine where to focus resources and develop trial management strategies to mitigate risks
and ultimately yield efficiency gains throughout a study.
Improving study quality
Xcellerate Monitoring has been proven to identify specific areas of concern at study sites, allowing
the CRO to address critical issues before they escalate. The system also strengthens study quality by
increasing the amount of clean data available, in addition to improving the accuracy of data sets.
Sponsors with Xcellerate Monitoring have reduced their study’s missing pages of data by as much as
60% and shown an average of 50% lower source data verification (SDV) backlog – critical issues that can
delay database lock and hamper a study’s progress.
1 | Company Confidential
Risk Monitoring
*CenterWatch Study
REDUCE MISSING
PAGES OF STUDY
DATA BY
60% LOWER SOURCE
DATA VERIFICATION
(SDV) BACKLOG
50%
Learn more about our drug development solutions at
www.covance.com/Xcellerate
Covance Inc., headquartered in Princeton, NJ, USA is the drug development business of Laboratory
Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the
marketing name for Covance Inc. and its subsidiaries around the world.
The Americas + 1.888.COVANCE (+1.888.268.2623) + 1.609.452.4440
Europe / Africa + 00.800.2682.2682 +44.1423.500888
Asia Pacific + 800.6568.3000 +65.6.5686588
© Copyright 2018 Covance Inc. SSCDS058-1118
A comprehensive, cost-effective system
The Xcellerate Monitoring solution is a technically advanced, cost-effective, proven data integration and
analytics platform that can meaningfully improve the quality and reduce the time and cost of the clinical
oversight process. Xcellerate Monitoring products include:
Benefits of Xcellerate Monitoring
▶ Integrated: helps identify and review risks from multiple angles and viewpoints
▶ Holistic: delivers solutions to all the various clinical trial team members
▶ Robust: offers a proven strategy for helping sponsors mitigate risks from multiple sources
▶ Effective: generates analytical visualizations to help prioritize targeted actions
▶ Efficient: enables streamlined clinical and safety reviews, from high-level overviews to outliers
▶ Compliant: provides an audit trail and history tracking to support adherence to ICH GCP and other
regulatory guidelines
Xcellerate Risk Review
Allows central monitors to assess and mitigate emerging
operational study, country and site risks and the resulting actions
Xcellerate CRA Dashboard
Delivers critical site and study data to on-the-go clinical research
associates via mobile device
Xcellerate Risk Assessment &
Categorization Tool (RACT)
Provides risk identification, scoring and mitigation planning
Xcellerate Medical Review
Enables physicians to assess patient safety, protocol deviations
and other clinical issues and share their observations
Xcellerate Statistical Review
Provides reviews for non-random anomalies in the distributions
of clinical site data
Xcellerate Data Review
Allows data managers to discern missing, erroneous or inconsistent
data, along with patient cleaning, tracking and querying
Xcellerate Risk & Issue Management
Facilitates reviews for non-random anomalies in the distributions
of clinical site data
*CenterWatch Study

Weitere ähnliche Inhalte

Was ist angesagt?

Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...Levi Shapiro
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreviewDaria Binder
 
Hfa progression 110706 e
Hfa progression 110706 eHfa progression 110706 e
Hfa progression 110706 eHossein Mirzaie
 
Xcellerate® Data Review
Xcellerate® Data Review Xcellerate® Data Review
Xcellerate® Data Review Covance
 
ADHB's Solution for Radiology Order Entry and Results Signoff
ADHB's Solution for Radiology Order Entry and Results SignoffADHB's Solution for Radiology Order Entry and Results Signoff
ADHB's Solution for Radiology Order Entry and Results SignoffHealth Informatics New Zealand
 
Laboratories for Diagnostic Testing
Laboratories for Diagnostic TestingLaboratories for Diagnostic Testing
Laboratories for Diagnostic TestingStatreferral
 
Real-Time Data. Real-World Impact. Info sheet
Real-Time Data. Real-World Impact. Info sheet Real-Time Data. Real-World Impact. Info sheet
Real-Time Data. Real-World Impact. Info sheet Covance
 
Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015Dan Diaz
 
Introduction to Reliability
Introduction to ReliabilityIntroduction to Reliability
Introduction to ReliabilityCMDLMS
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Covance
 
Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.Covance
 
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...Compliance Global Inc
 
mHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US Payers
mHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US PayersmHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US Payers
mHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US PayersLevi Shapiro
 
Precision Oncology adoption: The future is now
Precision Oncology adoption: The future is nowPrecision Oncology adoption: The future is now
Precision Oncology adoption: The future is nowaccenture
 
6764 precon slides for webcast loop
6764 precon slides for webcast loop6764 precon slides for webcast loop
6764 precon slides for webcast loopedpolanco
 
Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...
Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...
Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...BBCR Consulting
 
What Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real WorldWhat Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real WorldMedpace
 
Medisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth IsraelMedisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth IsraelLevi Shapiro
 

Was ist angesagt? (20)

Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
Hirshberg promise of digital technology astra_zenecaThe Promise of Digital Te...
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreview
 
Hfa progression 110706 e
Hfa progression 110706 eHfa progression 110706 e
Hfa progression 110706 e
 
Xcellerate® Data Review
Xcellerate® Data Review Xcellerate® Data Review
Xcellerate® Data Review
 
ADHB's Solution for Radiology Order Entry and Results Signoff
ADHB's Solution for Radiology Order Entry and Results SignoffADHB's Solution for Radiology Order Entry and Results Signoff
ADHB's Solution for Radiology Order Entry and Results Signoff
 
Laboratories for Diagnostic Testing
Laboratories for Diagnostic TestingLaboratories for Diagnostic Testing
Laboratories for Diagnostic Testing
 
Real-Time Data. Real-World Impact. Info sheet
Real-Time Data. Real-World Impact. Info sheet Real-Time Data. Real-World Impact. Info sheet
Real-Time Data. Real-World Impact. Info sheet
 
Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015
 
Introduction to Reliability
Introduction to ReliabilityIntroduction to Reliability
Introduction to Reliability
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
 
Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.Real-Time Data. Real-World Impact.
Real-Time Data. Real-World Impact.
 
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
 
mHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US Payers
mHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US PayersmHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US Payers
mHealth Israel_Ben Echeazu_Highmark Health_ Startups Engaging with US Payers
 
Precision Oncology adoption: The future is now
Precision Oncology adoption: The future is nowPrecision Oncology adoption: The future is now
Precision Oncology adoption: The future is now
 
6764 precon slides for webcast loop
6764 precon slides for webcast loop6764 precon slides for webcast loop
6764 precon slides for webcast loop
 
Making surgical practice improvement easy
Making surgical practice improvement easyMaking surgical practice improvement easy
Making surgical practice improvement easy
 
Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...
Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...
Cost-Effective Clinical Development with Strategic Clinical Innovation Organi...
 
What Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real WorldWhat Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real World
 
Medisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth IsraelMedisafe_What's Next in RWE_mHealth Israel
Medisafe_What's Next in RWE_mHealth Israel
 
Team 5-Final Project
Team 5-Final ProjectTeam 5-Final Project
Team 5-Final Project
 

Ähnlich wie Xcellerate® Monitoring

Risk Based Monitoring in Clinical Trials.
Risk Based Monitoring in Clinical Trials.Risk Based Monitoring in Clinical Trials.
Risk Based Monitoring in Clinical Trials.ClinosolIndia
 
Risk-based Monitoring Strategies for Improved Clinical Trial Performance
Risk-based Monitoring Strategies for Improved Clinical Trial PerformanceRisk-based Monitoring Strategies for Improved Clinical Trial Performance
Risk-based Monitoring Strategies for Improved Clinical Trial PerformanceCognizant
 
Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...
Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...
Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...Covance
 
Top 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - PepgraTop 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - PepgraPEPGRA Healthcare
 
Less is the New More
Less is the New MoreLess is the New More
Less is the New MoreKCR
 
Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...
Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...
Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...Health Catalyst
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
 
Defining a Central Monitoring Capability: Sharing the Experience of TransCele...
Defining a Central Monitoring Capability: Sharing the Experience of TransCele...Defining a Central Monitoring Capability: Sharing the Experience of TransCele...
Defining a Central Monitoring Capability: Sharing the Experience of TransCele...www.datatrak.com
 
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptx
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptxRisk Based Monitoring in Clinical trials_Aishwarya Janjale.pptx
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptxClinosolIndia
 
Robert E. Parson Resume
Robert E. Parson ResumeRobert E. Parson Resume
Robert E. Parson Resumebpstat
 
What Is Care?
What Is Care?What Is Care?
What Is Care?drjmdesai
 
10 most trusted clinical laboratories in 2021
10 most trusted clinical laboratories in 202110 most trusted clinical laboratories in 2021
10 most trusted clinical laboratories in 2021Merry D'souza
 
Challenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials DataChallenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials DataCitiusTech
 
Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueKishan Patel, MBA
 
How To Optimize Your EDC Solution For Risk Based Monitoring
How To Optimize Your EDC Solution For Risk Based MonitoringHow To Optimize Your EDC Solution For Risk Based Monitoring
How To Optimize Your EDC Solution For Risk Based Monitoringwww.datatrak.com
 
Revolutionizing Laboratory Management with Data-Driven Insights and Operation...
Revolutionizing Laboratory Management with Data-Driven Insights and Operation...Revolutionizing Laboratory Management with Data-Driven Insights and Operation...
Revolutionizing Laboratory Management with Data-Driven Insights and Operation...MocDoc
 
2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary 2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary The Avoca Group
 

Ähnlich wie Xcellerate® Monitoring (20)

Risk Based Monitoring in Clinical Trials.
Risk Based Monitoring in Clinical Trials.Risk Based Monitoring in Clinical Trials.
Risk Based Monitoring in Clinical Trials.
 
Risk-based Monitoring Strategies for Improved Clinical Trial Performance
Risk-based Monitoring Strategies for Improved Clinical Trial PerformanceRisk-based Monitoring Strategies for Improved Clinical Trial Performance
Risk-based Monitoring Strategies for Improved Clinical Trial Performance
 
Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...
Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...
Xcellerate Brochure - Successful Clinical Trials Begin and End with the Right...
 
Wincere Inc.
Wincere Inc.Wincere Inc.
Wincere Inc.
 
Top 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - PepgraTop 5 tips for managing risks in your clinical studies - Pepgra
Top 5 tips for managing risks in your clinical studies - Pepgra
 
Less is the New More
Less is the New MoreLess is the New More
Less is the New More
 
Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...
Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...
Network, Technology, and Data: Missing Pieces of the Puzzle for Clinical Tria...
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
Defining a Central Monitoring Capability: Sharing the Experience of TransCele...
Defining a Central Monitoring Capability: Sharing the Experience of TransCele...Defining a Central Monitoring Capability: Sharing the Experience of TransCele...
Defining a Central Monitoring Capability: Sharing the Experience of TransCele...
 
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptx
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptxRisk Based Monitoring in Clinical trials_Aishwarya Janjale.pptx
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptx
 
Robert E. Parson Resume
Robert E. Parson ResumeRobert E. Parson Resume
Robert E. Parson Resume
 
What Is Care?
What Is Care?What Is Care?
What Is Care?
 
Designing Risk Metrics for Risk-Based Monitoring
Designing Risk Metrics for Risk-Based MonitoringDesigning Risk Metrics for Risk-Based Monitoring
Designing Risk Metrics for Risk-Based Monitoring
 
10 most trusted clinical laboratories in 2021
10 most trusted clinical laboratories in 202110 most trusted clinical laboratories in 2021
10 most trusted clinical laboratories in 2021
 
Challenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials DataChallenges and Opportunities Around Integration of Clinical Trials Data
Challenges and Opportunities Around Integration of Clinical Trials Data
 
Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and value
 
How To Optimize Your EDC Solution For Risk Based Monitoring
How To Optimize Your EDC Solution For Risk Based MonitoringHow To Optimize Your EDC Solution For Risk Based Monitoring
How To Optimize Your EDC Solution For Risk Based Monitoring
 
Revolutionizing Laboratory Management with Data-Driven Insights and Operation...
Revolutionizing Laboratory Management with Data-Driven Insights and Operation...Revolutionizing Laboratory Management with Data-Driven Insights and Operation...
Revolutionizing Laboratory Management with Data-Driven Insights and Operation...
 
Sharing Knowledge - Lab outsourcing/Managemeent
Sharing Knowledge - Lab outsourcing/ManagemeentSharing Knowledge - Lab outsourcing/Managemeent
Sharing Knowledge - Lab outsourcing/Managemeent
 
2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary 2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary
 

Mehr von Covance

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Covance
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisCovance
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Covance
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsCovance
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCovance
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCovance
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCovance
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsCovance
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...Covance
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsCovance
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Covance
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramCovance
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketCovance
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceCovance
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochureCovance
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationCovance
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization TimelineCovance
 

Mehr von Covance (20)

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
 

Kürzlich hochgeladen

Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 

Kürzlich hochgeladen (20)

Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 

Xcellerate® Monitoring

  • 1. XCELLERATE® MONITORING Xcellerate Monitoring is an award-winning unique solution that mitigates clinical trial risk by integrating and managing operational, clinical and master data. Leverage near real-time data with risk-based, adaptive site monitoring to identify issues and trigger targeted actions that proactively mitigate threats to a clinical trial’s success. Overview In today’s competitive landscape, reducing risk is critical to prevent costly trial delays, which can result in sales losses of up to $8 million per day*. With traditional monitoring accounting for 20 to 30% of clinical trial costs, sponsors are revisiting their monitoring strategies to increase efficiencies, reduce risks and optimize results. Xcellerate Monitoring provides an innovative solution for the entire study team to integrate, centralize and visualize operational and clinical risk data with a tiered approach to risk assessment. With enhanced visibility into trial performance and risk-based monitoring (RBM) practices, the study team can determine where to focus resources and develop trial management strategies to mitigate risks and ultimately yield efficiency gains throughout a study. Improving study quality Xcellerate Monitoring has been proven to identify specific areas of concern at study sites, allowing the CRO to address critical issues before they escalate. The system also strengthens study quality by increasing the amount of clean data available, in addition to improving the accuracy of data sets. Sponsors with Xcellerate Monitoring have reduced their study’s missing pages of data by as much as 60% and shown an average of 50% lower source data verification (SDV) backlog – critical issues that can delay database lock and hamper a study’s progress. 1 | Company Confidential Risk Monitoring *CenterWatch Study REDUCE MISSING PAGES OF STUDY DATA BY 60% LOWER SOURCE DATA VERIFICATION (SDV) BACKLOG 50%
  • 2. Learn more about our drug development solutions at www.covance.com/Xcellerate Covance Inc., headquartered in Princeton, NJ, USA is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world. The Americas + 1.888.COVANCE (+1.888.268.2623) + 1.609.452.4440 Europe / Africa + 00.800.2682.2682 +44.1423.500888 Asia Pacific + 800.6568.3000 +65.6.5686588 © Copyright 2018 Covance Inc. SSCDS058-1118 A comprehensive, cost-effective system The Xcellerate Monitoring solution is a technically advanced, cost-effective, proven data integration and analytics platform that can meaningfully improve the quality and reduce the time and cost of the clinical oversight process. Xcellerate Monitoring products include: Benefits of Xcellerate Monitoring ▶ Integrated: helps identify and review risks from multiple angles and viewpoints ▶ Holistic: delivers solutions to all the various clinical trial team members ▶ Robust: offers a proven strategy for helping sponsors mitigate risks from multiple sources ▶ Effective: generates analytical visualizations to help prioritize targeted actions ▶ Efficient: enables streamlined clinical and safety reviews, from high-level overviews to outliers ▶ Compliant: provides an audit trail and history tracking to support adherence to ICH GCP and other regulatory guidelines Xcellerate Risk Review Allows central monitors to assess and mitigate emerging operational study, country and site risks and the resulting actions Xcellerate CRA Dashboard Delivers critical site and study data to on-the-go clinical research associates via mobile device Xcellerate Risk Assessment & Categorization Tool (RACT) Provides risk identification, scoring and mitigation planning Xcellerate Medical Review Enables physicians to assess patient safety, protocol deviations and other clinical issues and share their observations Xcellerate Statistical Review Provides reviews for non-random anomalies in the distributions of clinical site data Xcellerate Data Review Allows data managers to discern missing, erroneous or inconsistent data, along with patient cleaning, tracking and querying Xcellerate Risk & Issue Management Facilitates reviews for non-random anomalies in the distributions of clinical site data *CenterWatch Study